comparemela.com
14
15
16
17
18
19
20
Latest Breaking News On - Phillip chan - Page 13 : comparemela.com
CytoSorbents Reports First Quarter 2022 Results and Revises 2022 Outlook
/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.
Ireland
United-states
United-kingdom
State-of-new-jersey
New-jersey
Luxembourg
Austria
Russia
Brussels
Bruxelles-capitale
Belgium
London
CytoSorbents Highlights the Strategy of "Enhanced Lung Rest" Using CytoSorb with ECMO to Help Treat Lung Failure at the 10th EuroELSO Congress
/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.
Germany
United-states
Budapest
Hungary
Netherlands
Morgantown
Virginia
Italy
Russia
Ukraine
Maastricht
Limburg
CytoSorbents Highlights the Strategy of "Enhanced Lung Rest" Using CytoSorb with ECMO to Help Treat Lung Failure at the 10th EuroELSO Congress
/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.
Germany
United-states
Budapest
Hungary
Netherlands
Morgantown
Virginia
Italy
Russia
Ukraine
Maastricht
Limburg
CytoSorbents Highlights Activities at the Live 41st International Symposium on Intensive Care and Emergency Medicine (ISICEM)
/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.
Belgium
Germany
Eppendorf
Nordrhein-westfalen
United-states
India
Rome
Lazio
Italy
Austria
Russia
Ukraine
CytoSorbents Reports Fourth Quarter and Full Year 2021 Results and Provides 2022 Outlook
CytoSorbents Reports Fourth Quarter and Full Year 2021 Results and Provides 2022 Outlook Tweet this 2021 Total revenue, including product sales and grant
Russia
Germany
United-states
New-jersey
State-of-new-jersey
Belgium
Austria
Spain
Brussels
Bruxelles-capitale
Ukraine
Spanish
vimarsana © 2020. All Rights Reserved.